Ipratropium Bromide Inhalation
NDC 17270-0401, Ipratropium Bromide Inhalation, aerosol, from Armstrong Pharmaceuticals, Inc..
- Product NDC
- 17270-0401
- Status
- Listed
- Labeler
- Armstrong Pharmaceuticals, Inc.
- Dosage form
- AEROSOL
- Route
- RESPIRATORY (INHALATION)
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217953
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/17270-0401 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IPRATROPIUM BROMIDE17 ug/1
Pharmacologic classes
Anticholinergic [EPC]; Cholinergic Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 17270-0401-0 | 17270040100 | 1 CANISTER in 1 CARTON (17270-0401-0) / 200 AEROSOL in 1 CANISTER |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/133cc2ed-f018-4295-b84e-b24382299360NADAC price for package 17270040100
GET /v1/drugs/nadac/17270040100
Use it
Look up 17270-0401 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/17270-0401 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 17270-0401. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.